The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Tolerance and Persistence of Pseudomonas aeruginosa in Biofilms Exposed to Antibiotics: Molecular Mechanisms, Antibiotic Strategies and Therapeutic Perspectives
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Drug-tolerant persister cells arise as dormant but reversible subpopulations and are repeatedly associated with treatment failure and infection relapse [51,52,53].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 1×
“Thus, antibiotic treatment might be a determinant, hostile and unfavorable stressor which could eradicate susceptible nonpersister cells, and turn the scale toward the metabolic pathways of persistence (Balaban, 2004).”
BackgroundLewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Biofilm Formation: A Clinically Relevant Microbiological Process
Donlan, R. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322972 · Cited by 1,343
Definitions and guidelines for research on antibiotic persistence
Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0196-3 · Cited by 1,313
Fauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425
Molecular Mechanisms of HipA-Mediated Multidrug Tolerance and Its Neutralization by HipB
Schumacher, M. A., Piro, K. M., Xu, W., Hansen, S., Lewis, K., & Brennan, R. G. (2009) · Science · doi:10.1126/science.1163806 · Cited by 351
Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics
Defraine, V., Fauvart, M., & Michiels, J. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.002 · Cited by 222
Research works printed but not linked: 71
- Allison, 2011, Heterogeneous bacterial persisters and engineering approaches to eliminate them., Curr. Opin. Microbiol., 14, 593, 10.1016/j.mib.2011.09.002 · DOI · Paper page
- Baek, 2020, Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa., J. Antimicrob. Chemother., 75, 917, 10.1093/jac/dkz552 · DOI
- Bernier, 2013, Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin., PLoS Genet., 9, 10.1371/journal.pgen.1003144 · DOI · Paper page
- Biswas, 2012, Colistin: an update on the antibiotic of the 21st century., Expert Rev. Anti Infect. Ther., 10, 917, 10.1586/eri.12.78 · DOI · Paper page
- Bjarnsholt, 2005, Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent., Microbiol. Read. Engl., 151, 373, 10.1099/mic.0.27463-0 · DOI · Paper page
- Borriello, 2004, Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in Biofilms., Antimicrob. Agents Chemother., 48, 2659, 10.1128/AAC.48.7.2659-2664.2004 · DOI · Paper page
- Brackman, 2011, Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics In Vitro and In Vivo., Antimicrob. Agents Chemother., 55, 2655, 10.1128/AAC.00045-11 · DOI · Paper page
- Brauner, 2016, Distinguishing between resistance, tolerance and persistence to antibiotic treatment., Nat. Rev. Microbiol., 14, 320, 10.1038/nrmicro.2016.34 · DOI · Paper page
- Cao, 2015, Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model., J. Antimicrob. Chemother, 70, 2057, 10.1093/jac/dkv058 · DOI
- Chung, 2019, Eradication of persister cells of Acinetobacter baumannii through combination of colistin and amikacin antibiotics., J. Antimicrob. Chemother., 74, 1277, 10.1093/jac/dkz034 · DOI
- Ciofu, 2017, Antibiotic treatment of biofilm infections., APMIS, 125, 304, 10.1111/apm.12673 · DOI · Paper page
- Ciofu, 2019, Tolerance and resistance of Pseudomonas aeruginosa Biofilms to antimicrobial agents-how P. aeruginosa can escape antibiotics., Front. Microbiol., 10, 10.3389/fmicb.2019.00913 · DOI · Paper page
- Costerton, 1999, Bacterial biofilms: a common cause of persistent infections., Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
- De Groote, 2009, Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening., FEMS Microbiol. Lett., 297, 73, 10.1111/j.1574-6968.2009.01657.x · DOI
- de la Fuente-Núñez, 2014, Broad-spectrum anti-biofilm peptide that targets a cellular stress response., PLoS Pathog., 10, 10.1371/journal.ppat.1004152 · DOI · Paper page
- Del Pozo, 2018, Biofilm-related disease., Expert Rev. Anti Infect. Ther., 16, 51, 10.1080/14787210.2018.1417036 · DOI · Paper page
- Díez-Aguilar, 2015, Antimicrobial activity of fosfomycin-tobramycin combination against Pseudomonas aeruginosa Isolates assessed by time-kill assays and mutant prevention concentrations., Antimicrob. Agents Chemother., 59, 6039, 10.1128/AAC.00822-15 · DOI
- Dörr, 2009, SOS response induces persistence to fluoroquinolones in Escherichia coli., PLoS Genet., 5, 10.1371/journal.pgen.1000760 · DOI · Paper page
- Dörr, 2010, Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli., PLoS Biol., 8, 10.1371/journal.pbio.1000317 · DOI · Paper page
- Fernández-Barat, 2017, Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment., J. Cyst. Fibros., 16, 222, 10.1016/j.jcf.2016.08.005 · doi:10.1016/j.jcf.2016.08.005
- Fernández-Olmos, 2012, In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients., Int. J. Antimicrob. Agents, 40, 173, 10.1016/j.ijantimicag.2012.04.006 · doi:10.1016/j.ijantimicag.2012.04.006
- Gómez-Junyent, 2019, Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model., Int. J. Antimicrob. Agents, 53, 612, 10.1016/j.ijantimicag.2019.01.010 · DOI
- Haagensen, 2017, Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms., J. Antimicrob. Chemother., 72, 3357, 10.1093/jac/dkx288 · DOI
- Hall, 2017, Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria., FEMS Microbiol. Rev., 41, 276, 10.1093/femsre/fux010 · DOI · Paper page
- Harms, 2016, Mechanisms of bacterial persistence during stress and antibiotic exposure., Science, 354, 10.1126/science.aaf4268 · DOI · Paper page
- Hauryliuk, 2015, Recent functional insights into the role of (p)ppGpp in bacterial physiology., Nat. Rev. Microbiol., 13, 298, 10.1038/nrmicro3448 · DOI · Paper page
- Hazan, 2016, Auto poisoning of the respiratory chain by a quorum-sensing-regulated molecule favors biofilm formation and antibiotic tolerance., Curr. Biol., 26, 195, 10.1016/j.cub.2015.11.056 · DOI · Paper page
- Hengzhuang, 2013, High β-Lactamase levels change the pharmacodynamics of β-Lactam antibiotics in Pseudomonas aeruginosa biofilms., Antimicrob. Agents Chemother., 57, 196, 10.1128/AAC.01393-12 · DOI
- Hengzhuang, 2011, Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms., Antimicrob. Agents Chemother., 55, 4469, 10.1128/AAC.00126-11 · DOI · Paper page
- Hengzhuang, 2012, In Vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection., Antimicrob. Agents Chemother., 56, 2683, 10.1128/AAC.06486-11 · DOI · Paper page
- Kamble, 2020, Antibiotic tolerance in biofilm and stationary-phase planktonic cells of Staphylococcus aureus., Microb. Drug Resist., 10.1089/mdr.2019.0425 · DOI
- Keren, 2004, Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli., J. Bacteriol., 186, 8172, 10.1128/JB.186.24.8172-8180.2004 · DOI · Paper page
- Khakimova, 2013, The stringent response controls catalases in Pseudomonas aeruginosa and is required for hydrogen peroxide and antibiotic tolerance., J. Bacteriol., 195, 2011, 10.1128/JB.02061-12 · DOI · Paper page
- Klockgether, 2013, Intraclonal diversity of the Pseudomonas aeruginosa cystic fibrosis airway isolates TBCF10839 and TBCF121838: distinct signatures of transcriptome, proteome, metabolome, adherence and pathogenicity despite an almost identical genome sequence: genome and phenome diversity of P. aeruginosa clone TB., Environ. Microbiol., 15, 191, 10.1111/j.1462-2920.2012.02842.x · doi:10.1111/j.1462-2920.2012.02842.x
- Koo, 2017, Targeting microbial biofilms: current and prospective therapeutic strategies., Nat. Rev. Microbiol., 15, 740, 10.1038/nrmicro.2017.99 · DOI · Paper page
- Lebeaux, 2013, From in vitro to in vivo models of bacterial biofilm-related infections., Pathogens, 2, 288, 10.3390/pathogens2020288 · DOI · Paper page
- Lebeaux, 2014, Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics., Microbiol. Mol. Biol. Rev., 78, 510, 10.1128/MMBR.00013-14 · DOI · Paper page
- Lenz, 2008, Localized gene expression in Pseudomonas aeruginosa biofilms., Appl. Environ. Microbiol., 74, 4463, 10.1128/AEM.00710-08 · DOI · Paper page
- Li, 2016, HigB of Pseudomonas aeruginosa Enhances killing of phagocytes by up-regulating the Type III secretion system in ciprofloxacin induced persister cells., Front. Cell. Infect. Microbiol., 6, 10.3389/fcimb.2016.00125 · DOI · Paper page
- Lora-Tamayo, 2014, Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model., J. Antimicrob. Chemother., 69, 2434, 10.1093/jac/dku151 · DOI
- Lutz, 2012, Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm., BMC Microbiol., 12, 10.1186/1471-2180-12-196 · DOI
- Macià, 2011, Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment., Antimicrob. Agents Chemother., 55, 5230, 10.1128/AAC.00617-11 · DOI
- Macia, 2014, Antimicrobial susceptibility testing in biofilm-growing bacteria., Clin. Microbiol. Infect., 20, 981, 10.1111/1469-0691.12651 · DOI · Paper page
- Marchaim, 2019, Use of colistin in critically Ill patients., Adv. Exp. Med. Biol., 1145, 155, 10.1007/978-3-030-16373-0_12 · DOI
- Mensa, 2018, Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: guidelines by the Spanish society of chemotherapy., Rev. Espanola Quimioter. Publ. Soc. Espanola Quimioter., 31, 78
- Michiels, 2016, In Vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens., Antimicrob. Agents Chemother., 60, 4630, 10.1128/AAC.00757-16 · DOI
- Murakami, 2005, Role for rpoS gene of Pseudomonas aeruginosa in antibiotic tolerance., FEMS Microbiol. Lett., 242, 161, 10.1016/j.femsle.2004.11.005 · doi:10.1016/j.femsle.2004.11.005
- Nalca, 2006, Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach., Antimicrob. Agents Chemother., 50, 1680, 10.1128/AAC.50.5.1680-1688.2006 · DOI · Paper page
- Nguyen, 2011, Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria., Science, 334, 982, 10.1126/science.1211037 · DOI · Paper page
- Olivares, 2020, Clinical impact of antibiotics for the Treatment of Pseudomonas aeruginosa biofilm infections., Front. Microbiol., 10, 10.3389/fmicb.2019.02894 · DOI · Paper page
- Pamp, 2008, Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes., Mol. Microbiol., 68, 223, 10.1111/j.1365-2958.2008.06152.x · DOI · Paper page
- Pang, 2019, Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies., Biotechnol. Adv., 37, 177, 10.1016/j.biotechadv.2018.11.013 · DOI · Paper page
- Peyrusson, 2020, Intracellular Staphylococcus aureus persisters upon antibiotic exposure., Nat. Commun., 11, 10.1038/s41467-020-15966-7 · DOI · Paper page
- Pletzer, 2016, Anti-biofilm peptides as a new weapon in antimicrobial warfare., Curr. Opin. Microbiol., 33, 35, 10.1016/j.mib.2016.05.016 · DOI · Paper page
- Reffuveille, 2014, A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms., Antimicrob. Agents Chemother., 58, 5363, 10.1128/AAC.03163-14 · DOI · Paper page
- Rojo-Molinero, 2016, Sequential treatment of biofilms with aztreonam and tobramycin is a novel strategy for combating Pseudomonas aeruginosa chronic respiratory infections., Antimicrob. Agents Chemother., 60, 2912, 10.1128/AAC.00196-16 · doi:10.1128/aac.00196-16
- Roy, 2018, Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action., Virulence, 9, 522, 10.1080/21505594.2017.1313372 · DOI · Paper page
- Ruddy, 2013, Sputum tobramycin concentrations in cystic fibrosis patients with repeated administration of inhaled tobramycin., J. Aerosol. Med. Pulm. Drug Deliv., 26, 69, 10.1089/jamp.2011.0942 · DOI
- Schumacher, 2015, HipBA-promoter structures reveal the basis of heritable multidrug tolerance., Nature, 524, 59, 10.1038/nature14662 · DOI · Paper page
- Smith, 2006, Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients., Proc. Natl. Acad. Sci. U.S.A., 103, 8487, 10.1073/pnas.0602138103 · DOI · Paper page
- Soares, Efficacy of a ciprofloxacin/amikacin combination against planktonic and biofilm cultures of susceptible and low-level resistant Pseudomonas aeruginosa., J. Antimicrob. Chemother., 74, 3252, 10.1093/jac/dkz355 · DOI
- Soares, Understanding ciprofloxacin failure in pseudomonas aeruginosa biofilm: persister cells survive matrix disruption., Front. Microbiol., 10, 10.3389/fmicb.2019.02603 · DOI
- Sousa, 2014, Pseudomonas aeruginosa diversification during infection development in cystic fibrosis lungs—a review., Pathogens, 3, 680, 10.3390/pathogens3030680 · DOI · Paper page
- Stewart, 2020, Risk factors for chronic biofilm-related infection associated with implanted medical devices., Clin. Microbiol. Infect., 26, 1034, 10.1016/j.cmi.2020.02.027 · DOI · Paper page
- Stewart, 2008, Physiological heterogeneity in biofilms., Nat. Rev. Microbiol., 6, 199, 10.1038/nrmicro1838 · DOI · Paper page
- Viducic, 2006, Functional analysis of spoT, relA and dksA genes on quinolone tolerance in Pseudomonas aeruginosa under nongrowing condition., Microbiol. Immunol., 50, 349, 10.1111/j.1348-0421.2006.tb03793.x · DOI
- Wang, 2019, Synergistic activity of fosfomycin, ciprofloxacin, and gentamicin against Escherichia coli and Pseudomonas aeruginosa biofilms., Front. Microbiol., 10, 10.3389/fmicb.2019.02522 · DOI
- Werner, 2004, Stratified growth in Pseudomonas aeruginosa biofilms., Appl. Environ. Microbiol., 70, 6188, 10.1128/AEM.70.10.6188-6196.2004 · DOI · Paper page
- Williamson, 2012, Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population., J. Bacteriol., 194, 2062, 10.1128/JB.00022-12 · DOI · Paper page
- Wiuff, 2005, Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations., Antimicrob. Agents Chemother., 49, 1483, 10.1128/AAC.49.4.1483-1494.2005 · DOI · Paper page
- Yu, 2012, In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells., J. Antimicrob. Chemother., 67, 2673, 10.1093/jac/dks296 · DOI
Cited by
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Anderson, C. M., Mattenberger, Y., Parga, A., Portalier, H., Tan, C. A. Z., Esteban Henao, M., Viollier, P. H., & Kline, K. A. (2026) · Journal of Bacteriology · doi:10.1128/jb.00548-25 · Cited by 2
Metadata
- Authors
- Soares, A., Alexandre, K., & Etienne, M.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-08-27
- Volume
- 11
- ISSN
- 1664-302X
- Cited by
- 113
- References
- 7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tolerance and Persistence of Pseudomonas aeruginosa in Biofilms Exposed to Antibiotics: Molecular Mechanisms, Antibiotic Strategies and Therapeutic Perspectives. https://app.cochat.ai/papers/10.3389/fmicb.2020.02057
- The paper
- Soares, A., Alexandre, K., & Etienne, M. (2020). Tolerance and Persistence of Pseudomonas aeruginosa in Biofilms Exposed to Antibiotics: Molecular Mechanisms, Antibiotic Strategies and Therapeutic Perspectives. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2020.02057
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.